 - Disease-modifying drug naïve patients or patients with stable and adequately taken disease-modifying therapy interferon β-1, glatiramer acetate, or dimethyl fumarate for at least six months before inclusion NOTE: Other disease modifying drugs might be added at a later date, depending on the results of current investigations 